41
Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®
Condition(s):Formulation FindingLast Updated:June 21, 2012Completed
Pharmacokinetic Profile: 2162 Clinical Trials, Page 5 of 217
Hide Studies Not Open or Pending
42
Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Condition(s):Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of EnrollmentLast Updated:December 14, 2010Unknown status
43
A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
Condition(s):Healthy VolunteersLast Updated:January 31, 2019Completed
44
A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations
Condition(s):AnalgesiaLast Updated:November 24, 2014Completed
45
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
Condition(s):Cognitive DisordersLast Updated:September 25, 2017Completed
46
A Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes With Nicotine Salt Formulations
Condition(s):Healthy VolunteersLast Updated:January 30, 2019Completed
47
Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects
Condition(s):COVID-19; and High Infection Risk of SARS-CoV-2Last Updated:June 22, 2020Unknown status
48
A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product
Condition(s):HealthyLast Updated:September 23, 2015Completed
49
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
Condition(s):HealthyLast Updated:June 12, 2015Completed
50
Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
Condition(s):Renal FailureLast Updated:February 12, 2013Completed